MOXIE DWIGHT (SVP, GC & Secretary) sold 44.2% of their position (34.85K shares) of REVANCE THERAPEUTICS, INC. on the open market
Open‑market sale worth $612.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/7/2023ACC: 0001479290-23-000102
Officer· SVP, GC & Secretary
Since Feb 2020
-34.85K
Net shares
Net seller
$612.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
34.85K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−23.85K
Price / share
$17.81
Trade value
$424.92K
% of position
30.2%
9/5/2023
78.92K→55.07K
Common Stock
Direct
Shares
−11K
Price / share
$17.06
Trade value
$187.70K
% of position
20.0%
9/6/2023
55.07K→44.07K
Total
Net shares
−34.85K
Net value
-$612.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/5/2023 | S · Sale | −23.85K | $17.81 | $424.92K | 30.2% | 78.92K | 55.07K |
| Common Stock Direct | 9/6/2023 | S · Sale | −11K | $17.06 | $187.70K | 20.0% | 55.07K | 44.07K |
| Total | −34.85K | -$612.62K | ||||||
Derivative Transactions0
No derivative transactions reported